Buprenorphine Treatment in Community-Based Primary Care Chinazo Cunningham, MD, MS Associate Chief, General Internal Medicine Professor of Medicine
Establishing the Buprenorphine Treatment Program HRSA funding 2004 Care Team - 5 years, $1.9 million 1 site = CHCC - Integration of bupe & HIV treatment 3 MDs 1 PharmD = Bupe Coordinator
Buprenorphine Treatment Program – 10 years >900 patients, >25 prescribers Patients receiving buprenorphine treatment 1000 900 800 700 600 500 400 300 200 100 0 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
Expansion of the Buprenorphine Treatment Program Clinic CHCC CFCC FCC FHC Williamsbridge Bupe C. Cunningham T. Lu L. Khalid M. Gbur J. Bumol Champion Bupe A. Giovanniello D. Rodriguez D Rodriguez J. Margolis J. Margolis Coordinator PharmD RN RN LMSW LMSW Community Y. Holguin Y. Holguin Y. Holguin Y. Holguin Y. Holguin outreach Bupe M. Bachhuber M. Akiyama J. Starrels J. Kang P. Gross C. Beaudoin E. Harris S. Roth S. Donabonna L. Baron Prescribers R. Beil K. Cartmill L. Shapiro E. Tattleman M. Polisar O. Blackstock J. Pan V. Gorski D. O’Connol A. Fox G. Fung-Chow E. Goss M. Gover S. Iyer M. Kladney S. Mallik B. Norton A. Patel V. Patel K. Schaefle M. Yao-Cohen
Buprenorphine Treatment Strategies • Home induction tool kit (initiation of treatment) ASAM National Practice Guideline 2015; Sohler 2009; Cunningham 2011
Buprenorphine Treatment Strategies • Delivery of buprenorphine treatment – Model of care – Home induction – Group-based treatment – Induction at syringe exchange programs • “Appropriate” patient population – Polysubstance use – Chronic pain • Integrating buprenorphine treatment with other illnesses – HIV – Hepatitis C viral infection – Smoking Cunningham 2008, 2013; Fox 2012, 2015, 2016; Altice 2011; Fiellin 2011; Sullivan 2011; Norton 2017; Shah 2017; Nahvi 2014; Doorley 2017.
Recommend
More recommend